Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Sells $244,842.48 in Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 2,104 shares of the stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $116.37, for a total transaction of $244,842.48. Following the transaction, the chief financial officer now directly owns 20,647 shares of the company’s […]
More Stories
Hegseth, Rubio Brief Lawmakers on US Operation in Venezuela
By Joseph Lord and Nathan Worcester WASHINGTON—Secretary of War Pete Hegseth and Secretary of State Marco Rubio on Monday briefed...
Ford Reports Best Annual US Vehicle Sales in 8 Years as Hybrids, Trucks Offset EV Slowdown
By Tom Ozimek Ford Motor Company on Jan. 6 reported its strongest annual U.S. vehicle sales since 2019, buoyed by...
Trucking Insiders Reveal How Licensing System Enabled Illegal Immigrant Drivers
By Jacob Burg When a semi-truck driver made an illegal U-turn on the Florida Turnpike in August 2025, causing the...
Venezuelan Opposition Leader Machado Hails Trump for Capture of Maduro
By Kimberly Hayek Venezuelan opposition leader Maria Corina Machado celebrated President Donald Trump for making the decision to capture Nicolás...
Morgan Stanley Lifts Gold Forecast to $4,800, Citing Fed Cuts and Global Risk
By Tom Ozimek Gold prices are poised to climb to fresh record highs by the end of the year, with...
Key Takeaways From Maduro’s First Court Appearance
By Arjun Singh and Sam Dorman NEW YORK CITY—Deposed Venezuelan leader Nicolás Maduro and his wife, Cilia Flores, made their...